These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Parkinson's disease and dementia: a longitudinal study (DEMPARK). Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139 [TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment. Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N Front Neurosci; 2017; 11():712. PubMed ID: 29326545 [No Abstract] [Full Text] [Related]
25. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study. Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628 [TBL] [Abstract][Full Text] [Related]
27. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
28. Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment. Becker S; Boettinger O; Sulzer P; Hobert MA; Brockmann K; Maetzler W; Berg D; Liepelt-Scarfone I; J Alzheimers Dis; 2021; 79(1):197-209. PubMed ID: 33216023 [TBL] [Abstract][Full Text] [Related]
29. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease. Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441 [TBL] [Abstract][Full Text] [Related]
30. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog. Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719 [TBL] [Abstract][Full Text] [Related]
32. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study. Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711 [TBL] [Abstract][Full Text] [Related]